CLORAZEPATE DIPOTASSIUM
Active substance: clorazepate dipotassium
TABLET · CLORAZEPATE DIPOTASSIUM 7.5 mg/1
United StatesActive
Marketing holder: Aurolife Pharma LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- CLORAZEPATE DIPOTASSIUM · 7.5 mg/1
Import and control
Control by country
- United StatescontrolledSchedule: CIV
Source: openFDA NDC · record 01a1208c-489f-76c9-8ece-5af3602ea842,01a1208c-7c2c-70d4-9539-2ae8c604ee5b,01a1208c-be3a-7581-8f5f-4265335e66d5,01a1208e-03af-79d2-aaea-8c4b8651536f,01a1208e-6c51-7797-a15c-88849966c51d;count=25 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 13107-283
- Registration status
- Active
- Dispensing
- Prescription only
- Control marker
- CIV
- Route
- ORAL
Sources
- product · openFDA NDC · 13107-283 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 13107-283 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 13107-283 · Verified 2026-10-09 · open in source